Fin amputation and heart cryoinjury models for regenerative drug discovery
Zebrafish possess an extraordinary and rare capacity among vertebrates: they can fully regenerate an amputated fin, restoring exact original size, bony ray pattern, vasculature, innervation, and pigment stripes within about two weeks — making the fin one of the most tractable and widely used models for studying epimorphic regeneration.
The zebrafish caudal fin is thin, avascular at its distal tip, transparent enough for live imaging, and — critically — its amputation causes no threat to the animal's survival, unlike organ injury models. A standardized surgical amputation using a sterile scalpel or razor blade removes a defined distal fraction of the fin at a fixed, reproducible position relative to a landmark (such as the most proximal bifurcation point of the fin rays), and the fish can be returned immediately to its home tank, feeding and swimming normally throughout the entire multi-week regenerative process.
This combination of surgical simplicity, complete non-lethality, and the fin's essentially two-dimensional, opaque-to-transparent structure has made it the workhorse tissue for identifying the fundamental cellular and molecular logic of vertebrate epimorphic (blastema-based) regeneration.
The same individual zebrafish can have its fin amputated and imaged for regeneration repeatedly across its lifespan — the fin regenerates fully and indistinguishably from the original tissue every time, a striking demonstration that this is not a one-time embryonic capacity but a maintained adult regenerative program.
For screening purposes, amputation position, fish age, size, and genetic background are all tightly controlled, since regeneration rate scales with the amount of tissue removed and with individual fish size and metabolic state. A typical protocol amputates a fixed percentage (commonly 30-50%) of the fin's total length, or cuts at a defined landmark such as a specific fin ray bifurcation point visible under a dissecting scope, ensuring that regrowth measurements are directly comparable across a large cohort of fish in a screening experiment.
The caudal fin is composed of bony, segmented fin rays (lepidotrichia) arranged in parallel, each ray a bi-convex pair of dermal bone hemi-rays enclosing blood vessels, nerve fibers, and mesenchymal fibroblasts, all covered by a thin epidermal layer bearing melanophore and other pigment cell stripes. Regeneration must precisely rebuild all of these tissue types — bone, vasculature, nerve, connective tissue, and pigment pattern — in correct proportion and position, making the completeness and fidelity of fin regrowth a rich, multi-tissue readout for any compound or genetic perturbation under study.
Within the first hours after amputation, epidermal cells at the wound margin rapidly migrate to cover the exposed injury surface, forming a specialized structure called the wound epidermis — not merely a passive barrier, but an active signaling center that instructs the tissue beneath it to begin the regenerative program.
Unlike mammalian wound healing, which typically forms a fibrotic scar, the zebrafish fin amputation site is covered within hours by migrating epidermal cells that require no new cell division for this initial closure — existing epidermal cells simply flatten and migrate collectively to cover the wound surface, a much faster process than the proliferation-dependent healing seen in mammalian skin.
Over the following 12-24 hours, this initial covering thickens into a specialized multi-layered structure called the apical epidermal cap (analogous to the apical ectodermal ridge of the classic limb regeneration literature), which becomes a critical signaling hub rather than merely a physical barrier.
Neutrophils infiltrate the wound within the first few hours, followed by macrophages over the subsequent day. Far from being purely a defensive response, this inflammatory influx is now understood to be mechanistically required for successful regeneration: macrophage-derived signals are necessary for blastema formation, and experimentally depleting macrophages at this stage measurably impairs or blocks subsequent fin regrowth — establishing inflammation as an integrated, essential early step of the regenerative program rather than a process regeneration must first overcome.
This requirement for a controlled, transient inflammatory response — rather than its complete absence or unresolved chronic activation — is a recurring theme across regeneration-competent species and tissues, and a key reason why simply suppressing inflammation is not a viable strategy for enhancing mammalian regenerative capacity.
The apical epidermal cap secretes a defined set of signaling molecules — including Wnt/β-catenin pathway ligands, fibroblast growth factors (FGF), and bone morphogenetic proteins (BMP) — that diffuse into the underlying mesenchymal tissue and are required to trigger the dedifferentiation and proliferation of blastema progenitor cells in the next stage. Experimentally blocking any of these key signaling pathways at this stage prevents blastema formation entirely, even though wound closure itself proceeds normally, demonstrating that wound healing and blastema induction are mechanistically separable steps.
The blastema is the defining structure of epimorphic regeneration: a mass of proliferative, lineage-restricted progenitor cells that forms directly beneath the wound epidermis within 1-3 days post-amputation, generated not from stem cells but from mature cells that partially reverse their differentiated state.
For decades it was unclear whether the blastema arose from a rare resident population of multipotent stem cells or from ordinary mature cells reversing their differentiation state. Lineage-tracing experiments using genetically labeled cell populations resolved this: mature osteoblasts (bone-forming cells) near the amputation plane dedifferentiate — downregulating their mature bone-specific gene expression and re-entering the cell cycle — and contribute to the blastema, and similarly for other tissue types (fibroblasts, pigment cells, vascular and nerve-associated cells).
Remarkably, this dedifferentiation is largely lineage-restricted: dedifferentiated osteoblasts predominantly regenerate new bone, not new nerve or vessel tissue. The blastema is therefore better described as a transient pool of multiple distinct, lineage-committed progenitor populations working in parallel and in coordination, rather than a single uniform stem cell mass.
This lineage-restricted dedifferentiation model — mature cells partially reverting to a proliferative progenitor state while retaining a memory of their tissue of origin — is a fundamentally different regenerative strategy than mammalian wound repair, where analogous mature cells typically remain post-mitotic and the injury instead resolves via fibrotic scarring.
Blastema formation and proliferation require coordinated activity of several conserved developmental signaling pathways operating together: Wnt/β-catonin signaling drives blastema cell proliferation and is necessary and sufficient to promote outgrowth; FGF signaling (particularly FGF20a) is required for blastema formation and its loss blocks regeneration entirely; retinoic acid signaling helps re-establish proximodistal positional identity; and Bmp signaling contributes to bone ray patterning during the subsequent outgrowth phase. This overlapping use of core embryonic developmental pathways — redeployed in the adult during regeneration — is a recurring principle across regenerative biology.
Once established, the blastema drives rapid tissue outgrowth over the following 1-2 weeks, proliferating and progressively redifferentiating cells into new bone, blood vessels, nerve fibers, and pigment pattern — all correctly scaled and positioned to seamlessly match the pre-existing, uninjured portion of the fin.
As the blastema grows, it organizes into a graded structure along the proximodistal axis: cells at the most distal tip remain highly proliferative and undifferentiated, while cells further proximal (closer to the original uninjured tissue) begin redifferentiating into mature bone, vascular, and connective tissue, progressively "leaving behind" newly patterned tissue as the growing tip advances outward. This organization allows continuous outgrowth while simultaneously laying down mature, functional tissue behind the growing front, rather than requiring the entire structure to differentiate synchronously at the end of the process.
One of the most striking features of fin regeneration is that the regenerate reliably restores exactly the missing amount of tissue and stops — a fin amputated close to the body regrows more tissue than one amputated near the tip, yet both correctly restore the fin to its original full length, not a fixed increment. This implies cells retain some form of positional memory of their location along the proximodistal axis, encoded at least partly through gradients of retinoic acid signaling and specific transcription factor expression, allowing the regenerating tissue to sense its position relative to the body and titrate its growth accordingly, then terminate outgrowth once original proportions are restored.
This length-sensing and growth-termination mechanism — restoring exactly the missing tissue and no more — remains one of the most actively studied open questions in regeneration biology, since a therapeutic strategy to induce mammalian tissue regrowth would similarly require some mechanism to reliably halt growth once the correct size is achieved.
Because the fin regeneration timeline is fast, the anatomy is externally visible and photographable without sacrificing the animal, and the process is mechanistically conserved with more clinically relevant models such as cardiac and neural regeneration, the fin assay is widely used as a first-pass in vivo screen for compounds that accelerate, impair, or otherwise modulate vertebrate tissue regeneration.
Fish are amputated using the standardized protocol, then randomized into treatment groups where candidate compounds are added directly to tank water (small molecules readily absorbed through skin and gills, similar to embryo immersion dosing) continuously or during defined windows throughout the regenerative period. Fin regrowth is measured non-invasively at defined checkpoints — commonly 3, 7, and 14 days post-amputation — by photographing the fin under consistent conditions and measuring regenerate length or area using calibrated image analysis software, allowing the same individual fish to be tracked longitudinally across the entire regenerative timeline.
A pro-regenerative hit compound produces significantly greater regenerate length or area at a given timepoint compared to vehicle-treated controls, without producing toxicity or abnormal patterning (which would confound simple growth acceleration with a genuinely useful regenerative enhancement). Conversely, anti-regenerative or regeneration-impairing compounds — valuable both as tool compounds for studying the mechanism and as safety-liability flags for drugs in development — show delayed or incomplete regrowth, sometimes producing readily visible pattern defects: missing fin rays, disorganized vasculature, or blastema failure entirely.
Secondary, cell/molecular confirmatory assays (blastema marker gene expression by in situ hybridization, cell proliferation staining) are used to validate that a hit compound acts through a genuine regenerative mechanism rather than a nonspecific effect on general fish growth or metabolism.
Zebrafish are also one of the very few adult vertebrates capable of substantial cardiac muscle regeneration after injury — using a cryoinjury protocol that freezes and kills a defined region of ventricular myocardium, followed by a similar (though slower, weeks-to-months) blastema-like regenerative response driven by dedifferentiation and proliferation of surviving cardiomyocytes. Because adult mammalian, including human, hearts have only very limited endogenous regenerative capacity — heart attack damage is normally repaired by non-contractile scar tissue rather than new muscle — the zebrafish heart cryoinjury model has become a central platform for identifying the specific signaling pathways (many overlapping with fin regeneration: Nrg1/ErbB2, Notch, retinoic acid) that might, in principle, be reactivated or mimicked pharmacologically to promote a similar regenerative response in the injured human heart.
Compounds and pathways first identified as pro-regenerative in the fast, cheap, high-throughput zebrafish fin assay — including Wnt pathway agonists and specific retinoic acid signaling modulators — have gone on to show pro-regenerative activity in the much slower, more resource-intensive zebrafish heart cryoinjury model, illustrating the fin screen's value as an efficient upstream filter for regenerative medicine drug discovery.